Publisher： Adis International
ISSN： 1173-8324
Source： Inpharma, Vol.1, Iss.1424, 2004-01, pp. : 12-12
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Paclitaxel- and sirolimus-eluting stents produce comparable clinical outcomes in the real world
Inpharma, Vol. 1, Iss. 1595, 2007-01 ,pp. :
Access to resources
Recommend
Cost-effectiveness of sirolimus-eluting stents in AMI `debatable'
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 583, 2009-01 ,pp. :
Sirolimus-eluting stents superior in diabetes
Inpharma, Vol. 1, Iss. 1653, 2008-01 ,pp. :
Sirolimus-eluting stents beneficial for chronic total occlusions
Inpharma, Vol. 1, Iss. 1445, 2004-01 ,pp. :
Sirolimus-eluting stents "reasonably" cost effective in the US
Inpharma, Vol. 1, Iss. 1454, 2004-01 ,pp. :